New Jersey · 2026-2027 Regular Session · Bill
A 4699: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 4699 is a bill introduced in the New Jersey House on March 16, 2026. According to its official title, it concerns: Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer. Primary sponsor: Shanique Speight (Democratic), Sterley Stanley (Democratic), Donlon, Margie, M.D.. Most recent recorded action (March 16, 2026): Introduced, Referred to Assembly Financial Institutions and Insurance Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shanique Speight | Primary sponsor | Democratic | House | 29 |
| Sterley Stanley | Primary sponsor | Democratic | House | 18 |
| Donlon, Margie, M.D. | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee